Prevalence of angiotensin-converting enzyme, methylenetetrahydrofolate reductase, Factor V Leiden, prothrombin and apolipoprotein E gene polymorphisms in Morocco

References

• Bauduer F, Lacombe D. 2005. Factor V Leiden, prothrombin 20210a, methylenetetrahydrofolate reductase 677T, and population genetics. Mol Genet Metab. 86:91–99.
   PubMed Web of Science ®Google Scholar
• Bayoumi RA, Simsek M, Taher MY, Sheela B, Alhinai A, Al-barwani H, Hassan MO. 2006. Insertion–deletion polymorphism in the angiotensine-converting enzyme (ACE) gene among Sudanese, Somalis, Emiratis, and Omanis. Hum Biol. 78:103–108.
   PubMedGoogle Scholar
• Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, Van der Velden PA, Reitsma PH. 1994. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369:64–67.
   PubMed Web of Science ®Google Scholar
• Bouaziz L, Hézard N, Touhami M, Potron G, N'siri B, Guyen PN. 2004. Allelic frequency of the factor V Leiden mutation and of the prothrombin gene 20210A mutation in healthy Tunisian population. Thomb Haemost. 91:824–825.
   Google Scholar
• Caprini JA, Glase CJ, Anderson CB, Hathaway K. 2004. Laboratory markers in the diagnosis of venous thromboembolism. Circulation. 109:14–18.
   PubMed Web of Science ®Google Scholar
• Casas JP, Hingorani AD, Bautista LE, Sharma P. 2004. Meta-analysis of genetic studies in ischemic stroke: Thirty-two genes involving approximately 18000 cases and 58000 controls. Arch Neurol. 61:1652–1662.
   PubMed Web of Science ®Google Scholar
• Cavalli-Sforza LL, Menozzi P, Piazza A. 1994. The history and geography of human genes. Princeton, NJ: Princeton University Press.
   Google Scholar
• Cavalli-Sforza LL, Piazza A, Menozzi P, Montain J. 1988. Reconstruction of human evolution: Bringing together genetic, archeological and linguistic data. Proc Natl Acad Sci USA. 85:6002–6006.
   PubMed Web of Science ®Google Scholar
• Corbo RM, Scacchi R. 1999. Apolipoprotein E (APOE) allele distribution in the world: Is APOE*4 a ‘thrifty’ allele?. Ann Hum Genet. 63:301–310.
   PubMed Web of Science ®Google Scholar
• Coudray C, Guitard E, Lemaire O, Cherkaoui M, Baali A, Hilali K, Sevin A, Kandil M, Harich N, Melhaoui M, Larrouy G, Moral P, Dugoujon JM. 2004. Les allotypes Gm des immunoglobulines chez les Berbères du Maroc. Antropo. 6:63–69 www.didac.ehu.es/antropo.
   Google Scholar
• Danneberg J, Abbes AP, Bruggeman BJ. 1998. Reliable genotyping of the G-20210A mutation of coagulation factor II (prothrombin). Clin Chem. 44:349–351.
   Google Scholar
• Donnelly LA, Palmer CNA, Whitley AL, Lang CC, Doney ASF, Morris AD, Donnan PT. 2008. Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: A Go-DARTS study. Pharmacogenet Genomics. 18:279–287.
   PubMed Web of Science ®Google Scholar
• Erdos E, Skidgel RA. 1987. The angioensin I-converting enzyme. Lab Invest. 56:345–348.
   PubMed Web of Science ®Google Scholar
• Fadhlaoui-Zid K, Sanchez-Mazas A, Buhler S, Khodjet Ellkhill H, Ben Amor M, Comas D, Dugoujon JM, Slama H, Ammar Elgaaeid AB. 2009. Caractérisation génétique des isolats berbérophones du Sud tunisien par confrontation des résultats de trois marqueurs Polymorphes. Antropo. 18:73–86.
   Google Scholar
• Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. 1995. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet. 10:111–113.
   PubMed Web of Science ®Google Scholar
• Gandrille S, Alhenc-Gelas M, Aiach M. 1995. A rapid screening method for the factor V Arg506? Gln mutation. Blood Coagul Fibrinolysis. 6:245–248.
   PubMed Web of Science ®Google Scholar
• Gialeraki A, Politou M, Loukianos R, Merkouri E, Markatos C, Kremastinos D, Travlou A. 2008. Prevalence of prothrombotic polymorphisms in Greece. Genet Test. 12:541–547.
   PubMedGoogle Scholar
• Hixson JE, Vernier DT. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res. 31:545–548.
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Ntzani EE, Trikalinos TA. 2004. Racial differences in genetic effects for complex diseases. Nat Genet. 36:1243–1244.
   Google Scholar
• Jurka J. 2004. Evolutionary impact of human Alu repetitive elements. Curr Opin Genet Devel. 14:603–608.
   PubMedGoogle Scholar
• Lahlali-Kacemi N, Bamou Y, Guedira A, Hassani M, Visvikis S, Siest G, Alami N, Kabbaj O, Lahrichi M. 2002. Polymorphisme de l'apolipoprotéine E dans une population marocaine: Fréquence allélique et relation avec les paramètres lipidiques plasmatiques. Ann Biol Clin. 60:73–78.
   PubMedGoogle Scholar
• Lane DA, Grant PJ. 2000. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood. 95:1517–1532.
   PubMed Web of Science ®Google Scholar
• Mathonnet F, Nadifi S, Serazin-Leroy V, Dakouane M, Giudicelli Y. 2002. Absence of Factor V Leiden mutation and low prothrombin G 20210 A mutation prevalence in a healthy Moroccan population. Thromb Haemost. 88:1073–1074.
   Google Scholar
• Poort S, Rosendaal F, Reitsma P, Bertina R. 1996. A common genetic variation in the 3–ntranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 88:3698–3703.
   PubMed Web of Science ®Google Scholar
• Rahimy MC, Krishnamoorthy R, Ahouignan G, Laffan M, Vullialy T. 1998. The 20210 A allele of prothrombin is not found among sickle cell disease patients from west Africa. Thromb Haemost. 79:444–445.
   Google Scholar
• Ridker PM, Miletich JP, Stampfer MJ, Goldhaber SZ, Lindpaintner K, Hennekens CH. 1995. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation. 92:2800–2802.
   PubMed Web of Science ®Google Scholar
• Rigat B, Hubert C, Corvol P, Soubrier F. 1992. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 20:1433.
   PubMed Web of Science ®Google Scholar
• Rodriguez S, Gaunt TR, Day INM. 2009. Hardy–Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol. 169:505–514.
   PubMed Web of Science ®Google Scholar
• Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Ernardi F, Cumming AM, Preston FE, Reitsma PH. 1998. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 79:706–708.
   PubMed Web of Science ®Google Scholar
• Saidi S, Slamia LB, Ammou SB, Mahjoub T, Almawi WY. 2007. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels. J Stroke Cerebrovasc Dis. 16:160–166.
   PubMedGoogle Scholar
• Shanmugam V, Sell KW, Saha BK. 1993. Mistyping ACE heterozygotes. Genome Res. 3:120–121.
   Google Scholar
• Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Redlund M. 2003. Geographical and ethnic variation of the 677C > T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): Findings from over 7000 newborns from 16 areas worldwide. J Med Genet. 40:619–625.
   PubMed Web of Science ®Google Scholar
• Zivelin A, Rosenberg N, Faier S, Kornbrot N, Peretz H, Mannhalter C, Horellou MH, Seligsohn U. 1998. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood. 92:1119–1124.
   Google Scholar